Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $18.49 $27.02 Thursday, 9th May 2024 ANAB stock ended at $26.23. This is 1.86% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 4.65% from a day low at $25.37 to a day high of $26.55.
90 days $18.49 $27.48
52 weeks $13.36 $27.48

Historical AnaptysBio Inc prices

Date Open High Low Close Volume
May 09, 2024 $25.77 $26.55 $25.37 $26.23 215 459
May 08, 2024 $25.36 $26.01 $25.23 $25.75 231 846
May 07, 2024 $25.97 $26.50 $25.17 $25.68 315 746
May 06, 2024 $26.60 $26.60 $25.29 $25.77 192 955
May 03, 2024 $26.76 $27.02 $25.69 $26.58 326 029
May 02, 2024 $26.26 $26.74 $24.75 $26.34 317 726
May 01, 2024 $24.38 $26.35 $24.38 $26.02 784 646
Apr 30, 2024 $21.26 $24.50 $21.03 $24.34 1 023 670
Apr 29, 2024 $21.02 $22.74 $21.02 $21.30 709 001
Apr 26, 2024 $18.92 $21.61 $18.72 $21.00 643 320
Apr 25, 2024 $18.87 $19.30 $18.49 $18.87 391 364
Apr 24, 2024 $19.01 $19.29 $18.71 $19.27 300 785
Apr 23, 2024 $19.52 $20.48 $19.17 $19.18 381 270
Apr 22, 2024 $19.93 $20.27 $19.60 $19.66 136 597
Apr 19, 2024 $19.61 $20.66 $19.08 $19.87 281 568
Apr 18, 2024 $21.29 $21.78 $19.79 $19.83 355 411
Apr 17, 2024 $21.27 $21.56 $20.83 $21.47 286 569
Apr 16, 2024 $21.55 $22.15 $21.03 $21.34 238 948
Apr 15, 2024 $22.56 $23.10 $21.07 $21.27 263 164
Apr 12, 2024 $24.89 $24.94 $22.53 $22.71 338 683
Apr 11, 2024 $24.81 $25.62 $23.86 $24.73 564 517
Apr 10, 2024 $21.08 $22.43 $20.71 $22.17 345 663
Apr 09, 2024 $20.61 $21.82 $20.38 $21.53 419 125
Apr 08, 2024 $21.08 $21.50 $20.67 $20.67 118 947
Apr 05, 2024 $21.05 $21.49 $20.80 $21.08 130 130
Click to get the best stock tips daily for free!

About AnaptysBio Inc

AnaptysBio AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress... ANAB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT